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Abstract
Objectives—We evaluated HIV testing and service delivery in Centers for Disease Control and 
Prevention (CDC)–funded sexually transmitted disease (STD) clinics.
Methods—We assessed HIV testing, HIV positivity, receipt of HIV test results, linkage to 
medical care, and referral services from 61 health department jurisdictions from 2011 to 2013.
Results—In 2013, 18.6% (621 010) of all CDC-funded HIV-testing events were conducted in 
STD clinics, and 0.8% were newly identified as HIV-positive. In addition, 27.3% of all newly 
identified HIV-positive persons and 30.1% of all newly identified HIV-positive men who have sex 
with men were identified in STD clinics. Linkage to care within any time frame was 63.8%, and 
linkage within 90 days was 55.3%. Although there was a decrease in first-time HIV testers in STD 
clinics from 2011 to 2013, identification of new positives increased.
Conclusions—Although linkage to care and referral to partner services could be improved, STD 
clinics appear successful at serving populations disproportionately affected by HIV. These clinics 
may reach persons who may not otherwise seek HIV testing or medical services and provide an 
avenue for service provision to these populations.
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More than 1.2 million people are living with HIV in the United States, and approximately 
14% are not diagnosed.1,2 Although HIV incidence has remained stable over the past several 
years, some groups are disproportionately affected by HIV, particularly gay men, bisexual 
men, and other men who have sex with men (collectively referred to as MSM) as well as 
racial/ethnic minority populations, specifically Blacks or African Americans (hereinafter 
referred to as African Americans) and Hispanics or Latinos.3,4 Men who have sex with men 
account for approximately 2% of the US population.5,6 However, they accounted for 63% of 
all new HIV infections in 2010 and 54% of people living with HIV in 2011.1,3 In addition, 
although African Americans account for 12% of the US population, they accounted for 44% 
of all new HIV infections in 2010 and 41% of people living with HIV in 2011.1,3 In 2013, 
the rate of HIV diagnoses was 55.9 (per 100 000) for African Americans, in comparison 
with 18.7 for Hispanics or Latinos and 6.6 for Whites.7 Finally, Hispanics or Latinos 
account for approximately 17% of the US population,8 but accounted for 21% of new HIV 
infections in 2010 and 20% of people living with HIV in 2011.1,3
The Centers for Disease Control and Prevention (CDC) recommends routine HIV screening 
in health care settings, including sexually transmitted disease (STD) clinics, for clients aged 
13 to 64 years where prevalence is 0.1% or more.9 HIV testing and knowledge of HIV status 
are the first steps along the HIV continuum of care and serve as an important entry point to 
prevention services and linkage to HIV medical care. Previous research has indicated that 
early initiation of antiretroviral therapy has substantial medical benefits to HIV-positive 
individuals and prevention benefits to their HIV-negative partners by reducing transmission 
by up to 96%.10,11 The National HIV/AIDS Strategy12 has also emphasized the importance 
of knowledge of HIV status, reducing health-related disparities, and treatment as prevention, 
particularly increasing access to HIV medical care and strengthening linkage and retention 
in care. In light of the national priorities to reduce new HIV infections, it is important to gain 
a better understanding of HIV testing programs and service delivery to populations who may 
be at high risk for HIV infection.
Sexually transmitted disease clinics often serve minority populations and persons who may 
be economically disadvantaged, have limited access to health care, and have comorbid 
physical and medical concerns.13,14 As reflected by high coinfection rates between HIV and 
several STDs,15 STD clinics often reach clients who are at high risk for HIV infection and 
who may be unaware of their HIV status.13,16,17 In addition, they are more likely to reach 
clients who are younger, male, African American, and heterosexual persons who are at high 
risk for HIV infection, as well as MSM.13,18–20 Previous studies have indicated that STD 
clinics report a higher frequency of HIV testing than other health care settings and are more 
likely to identify persons who are HIV-positive.13,20,21
The STD clinics provide essential sexual health services to clients who may not otherwise 
have access to health care services but are at high risk for HIV infection. We evaluated HIV 
testing and HIV service delivery among CDC-funded STD clinics in 2013. To our 
knowledge, this is one of the first articles to present national-level program data from STD 
clinics on HIV testing and HIV service delivery. Our aims were to assess
1. HIV testing, including first-time testers;
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2. identification of newly diagnosed HIV-positive persons;
3. linkage to HIV medical care;
4. referral and interview for partner services; and
5. referral to HIV prevention services.
In addition, we compared the proportion of HIV testing and identification of new HIV-
positive persons that occurred in STD clinics with national data from all CDC-funded sites. 
Finally, we examined the demographic characteristics of the populations who received HIV 
services in STD clinics and the differences in HIV testing and HIV service delivery in CDC-
funded STD clinics from 2011 to 2013.
METHODS
The CDC funds state and local health departments to provide HIV testing and prevention 
services, and data are collected as part of CDC’s National HIV Prevention Program 
Monitoring and Evaluation (NHM&E). In 2011, CDC funded 59 health department 
jurisdictions for HIV testing, and in 2012 and 2013 funded 61 for this activity. Data for each 
CDC-funded HIV testing event are collected by local service providers and submitted to 
CDC biannually without personal identifiers via a secure, online CDC-provided system. The 
CDC uses these data for monitoring and evaluation of HIV testing and HIV-related service 
delivery.
For analyses of 2013 data, we included only HIV testing events and the corresponding data 
on HIV service delivery in STD clinics from the 61 health department jurisdictions 
submitted to CDC by June 2, 2014. For analyses on HIV testing and service delivery from 
2011 to 2013, we included data from all jurisdictions submitting complete, test-level data for 
each year. We defined an STD clinic as a health care facility that specializes in sexual health 
and in the prevention and treatment of STDs.
Measures
Demographics—For each test event, we collected self-reported data on gender, race/
ethnicity, and age. In terms of select target populations, we categorized male clients who 
reported male-to-male sexual contact in the past 12 months as MSM. We categorized clients 
as transgender if their self-reported current gender was different from their self-reported 
gender at birth. Finally, heterosexual male clients were defined as male clients who only 
reported heterosexual contact with a female partner in the past 12 months, and heterosexual 
female clients were female clients who only reported heterosexual contact with a male 
partner in the past 12 months. The CDC requires the collection of risk behavior data to 
calculate target populations for all HIV-testing events in non–health care settings (e.g., HIV 
counseling and testing sites, community-based organizations) and only for HIV-positive 
testing events in health care settings. However, some jurisdictions provided risk behavior 
data for HIV-negative testing events conducted in health care settings, and we have included 
these data in analyses. In STD clinics, data for 369 250 testing events were either required 
for target populations or available for HIV-negative testing events. Other target populations 
(e.g., injection drug users), HIV-positive persons who did not report injection drug use or 
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sexual behavior in the past 12 months, or missing data that are not presented in this article 
comprise 7541 of the 369 250 testing events among target populations in STD clinics.
HIV testing events—We defined HIV testing events as all records submitted to the 
National HIV Prevention Program Monitoring and Evaluation online data system, for which 
a test technology (conventional, rapid, nucleic acid amplification RNA testing, or other) or 
test result (positive, negative, indeterminate, or invalid) was reported. We defined first-time 
testers as HIV testing events among clients who did not report having a previous HIV test. 
Newly identified HIV-positive persons were those who tested HIV-positive during the 
current test event but did not self-report a previous HIV test or a previous HIV-positive test 
result.
Linkage to HIV medical care—We defined linkage as attendance at first medical 
appointment for clients who tested HIV-positive. We examined linkage for all newly 
identified HIV-positive persons. The National HIV/AIDS Strategy12 has a goal for 2015 that 
85% of persons newly diagnosed with HIV are linked to HIV medical care within 90 days of 
diagnosis. Therefore, we assessed and analyzed linkage within 90 days and linkage within 
any time frame (which includes linkage within 90 days and greater than 90 days).
Referral and interview for partner services—Partner services are a set of 
confidential, voluntary services to help persons with HIV notify their sexual and drug-
injection partners of possible HIV exposure, to offer services that can protect the health of 
partners, and to prevent STD reinfection.22 We considered clients who were either referred 
to or interviewed for partner services “referred.” We considered clients who were asked and 
provided information for partner services “interviewed.” We examined referral and interview 
for partner services for all newly identified HIV-positive persons.
Referral to HIV prevention services—We defined HIV prevention services as any 
service or intervention directly aimed at reducing risk for transmitting or acquiring HIV 
infection (e.g., prevention counseling, behavioral interventions, risk-reduction counseling).23 
It excludes HIV posttest counseling and indirect services such as mental health services or 
housing. We examined referral to HIV prevention services for all newly identified HIV-
positive persons.
Data Analysis
We calculated descriptive statistics to examine the frequency of HIV testing and other HIV 
service delivery in STD clinics by client characteristics. Denominators are included in tables 
for clarity and ease of interpretation.
We conducted χ2 analyses to examine change in percentage of newly identified HIV-positive 
persons and linkage to HIV medical care in STD clinics from 2011 to 2013. We only 
examined linkage to HIV medical care within 90 days from 2012 to 2013, as this variable 
was not required by CDC in 2011. We performed all statistical analyses in SAS version 9.3 
(SAS Institute Inc, Cary, NC).
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In 2013, 3 343 633 CDC-funded HIV testing events were conducted in the United States. 
Sexually transmitted disease clinics accounted for 18.6% (621 010) of all CDC-funded HIV 
testing events (Table 1). The STD clinics accounted for 22.7% of testing events among all 
persons aged 20 to 29 years, 20.9% among all African Americans, approximately 17.0% 
among all MSM and all African American MSM, 28.1% among all African American 
heterosexual male clients, 21.4% among all Hispanic or Latino male clients, and 20.6% 
among all African American heterosexual female clients. Of all HIV first-time testers, 
17.2% were identified in STD clinics in 2013. Also, 20.8% of all first-time testers aged 20 to 
29 years, 17.6% of all African American MSM first-time testers, 27.2% of all African 
American heterosexual male first-time testers, 20% of all Hispanic or Latino male first-time 
testers, and 20.1% of all African American heterosexual female first-time testers were 
identified in STD clinics (Table 1).
Of the 621 010 HIV testing events conducted in STD clinics, approximately half were 
among persons aged 20 to 29 years (49.7%) and African Americans (50.7%). More male 
clients (52.2%) were tested than female clients (47.2%). Of the 369 250 HIV-testing events 
in STD clinics among target populations, heterosexual female clients accounted for 44.5% of 
testing events, and 22.7% were among African American heterosexual female clients. 
Heterosexual male clients accounted for 41.6% of these testing events, and 22.8% were 
among African American heterosexual male clients. Finally, MSM and transgender persons 
accounted for 11.5% and 0.4%, respectively, of testing events conducted in STD clinics 
(Table 2).
We found a higher percentage of first-time HIV testers among persons aged 13 to 19 years 
(34.7%), Hispanic or Latino heterosexual male clients (33.4%), and all heterosexual male 
clients (28.0%). There also was a higher percentage of first-time testers among male clients 
(20.0%) than female clients (15.2%). Among target populations, 15.6% of African American 
MSM tested in STD clinics were first-time testers, followed by 13.5% of all MSM, and 
11.7% of Hispanic or Latino MSM. Approximately 19% of transgender persons were first-
time testers. Finally, 21.0% of Hispanic or Latino heterosexual female clients in STD clinics 
were first-time testers, followed by 20.1% of all heterosexual female clients, and 15.3% of 
African American heterosexual female clients (Table 2).
Newly Identified HIV-Positive Persons
Newly identified HIV-positive persons (17 426) accounted for 0.5% of all CDC-funded 
testing events in 2013, and 27.3% (4766) of all these persons were identified in STD clinics 
in 2013. The STD clinics accounted for 29.9% of newly identified HIV-positive persons 
among all persons aged 20 to 29 years and approximately 27% each among Whites, African 
Americans, and Hispanics or Latinos. Also, 28.7% of the newly identified HIV-positive male 
clients and 23.0% of the female clients were found in STD clinics. Finally, almost 30.0% of 
the newly identified HIV-positive persons among all African American and Hispanic or 
Latino MSM and all MSM overall, approximately 28.0% among all African American and 
Hispanic or Latino heterosexual male clients and all heterosexual male clients overall, and 
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approximately 27.0% of African American and Hispanic or Latino heterosexual female 
clients and all heterosexual female clients overall were found in STD clinics (Table 1).
In 2013, the HIV-positivity percentage among newly identified HIV-positive persons was 
0.8% in STD clinics. The highest percentage of newly identified HIV-positive persons was 
identified among African American MSM (10.5%), Hispanic or Latino and all MSM overall 
(5.6%), and transgender persons (1.7%). In addition, 1.0% of persons aged 40 to 49 years 
and 1.1% of persons aged 50 years and older were newly identified as HIV-positive; 1.0% of 
Hispanics or Latinos were newly identified as HIV-positive compared with 0.8% of African 
Americans. Finally, 1.2% of male clients were newly identified HIV-positive persons in STD 
clinics compared with 0.2% of female clients. Of the 4766 newly identified HIV-positive 
persons in STD clinics, 84% (n = 4007) were male clients, 55.1% (n = 2624) were African 
Americans, 49.8% (n = 2373) were MSM, and 43.2% (n = 2061) were persons aged 20 to 29 
years (Table 2).
Linkage to HIV Medical Care and Referral Services
Among the 4766 newly identified HIV-positive persons identified in STD clinics, 63.8% 
were linked to HIV medical care within any time frame following their HIV-positive 
diagnosis. Linkage within any time frame was generally comparable across age and gender. 
However, African Americans (54.5%) were linked within any time frame less frequently 
than Whites (70.6%) and Hispanics or Latinos (81.0%). In addition, heterosexual male 
clients (56.6%) were linked less than MSM (72.7%) and transgender persons (75.0%). 
Among newly identified HIV-positive persons, 55.3% were linked to HIV medical care 
within 90 days. Linkage within 90 days was generally comparable across age and gender. 
However, African Americans (47.0%) were linked within 90 days less frequently than 
Whites (59.3%) and Hispanics or Latinos (71.7%). In addition, heterosexual male clients 
(49.0%) and heterosexual female clients (58.0%) were linked less often than MSM (67.1%) 
and transgender persons (75.0%; Table 2).
Almost three quarters (73.5%) of newly identified HIV-positive individuals were referred to 
HIV partner services. Referral percentages were generally comparable across age and 
gender. African Americans (66.1%) were referred to partner services less often than Whites 
(76.7%) and Hispanics or Latinos (88.3%). Heterosexual male clients (71.6%) and 
heterosexual female clients (72.5%) were referred less often than MSM (88.1%) and 
transgender persons (83.3%). However, referral for Hispanic or Latino heterosexual male 
and female clients was approximately 94.0%. Among those newly identified as HIV-
positive, 62.2% were interviewed for HIV partner services (84.6% of those referred), and 
interview percentages were similar across age and gender. African Americans (54.8%) were 
interviewed for partner services less often than were Whites (64.6%) and Hispanics or 
Latinos (78.0%). Heterosexual male clients (59.5%) and heterosexual female clients (62%) 
were interviewed less often than MSM (74.8%) and transgender persons (75.0%). However, 
interview percentages for Hispanic or Latino heterosexual male and female clients were 
84.9% and 88.9%, respectively (Table 2).
Finally, 66.9% of newly identified HIV-positive persons were referred to HIV-prevention 
services, and referral percentages were similar across age and gender. Whites (66.8%) and 
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African Americans (62.3%) were referred less often than Hispanics or Latinos (76.6%). 
Heterosexual male clients (64.3%) and heterosexual female clients (70.1%) were referred 
less often than MSM (78.8%) and transgender persons (79.2%). However, referral 
percentages for Hispanic or Latino heterosexual male and female clients were 79.2% and 
88.9%, respectively (Table 2).
From 2011 to 2013, there was an increase in the number of CDC-funded HIV testing events 
conducted in STD clinics from 2011 (467 676) to 2013 (621 010) but a slight decrease from 
2012 (635 410) to 2013 (621 010). The χ2 analyses revealed that the percentage of first-time 
HIV testers in STD clinics significantly decreased each year (P < .01). However, the 
percentage of newly identified HIV-positive persons significantly increased each year from 
0.6% in 2011 to 0.8% in 2013 (P < .01; Figure 1). In addition, percentages for linkage to 
HIV medical care within any time frame and linkage within 90 days significantly increased 
each year (P < .01; Figure 2).
DISCUSSION
We found that STD clinics accounted for 18.6% of all CDC-funded HIV testing events and 
27.3% of all newly identified HIV-positive persons from CDC-funded tests in 2013. Overall, 
0.8% of all persons tested in STD clinics were newly identified as HIV-positive, compared 
with 0.5% of those at all CDC-funded testing events in 2013. In addition, among CDC-
funded tests, STD clinics identified approximately 30.0% of all newly identified HIV-
positive African American MSM, Hispanic or Latino MSM, and MSM overall in 2013, 
suggesting that STD clinics are successful at reaching these populations at higher risk. Half 
of all CDC-funded testing events in STD clinics were conducted among African Americans, 
and more than one third of Hispanic or Latino heterosexual male clients tested in STD 
clinics were first-time HIV testers. Finally, although MSM accounted for 11.5% of testing 
events in STD clinics, they accounted for 50% of newly identified HIV-positive persons, and 
African Americans accounted for 55% of newly identified HIV-positive persons. These 
findings are consistent with previous findings indicating that STD clinics serve populations 
who are disproportionately at risk for HIV.13,16–20
For finding new cases of HIV, STD clinics appear to be a relatively efficient venue, 
especially if the comparison is extended beyond the CDC-funded testing noted previously. 
Estimates for the proportion of persons (aged 18–64 years) in the United States tested in any 
recent year fall between 10.0% and 22.0% depending on the year and source.24,25 Drawing 
from Census Bureau projections of 196.5 million US residents aged 18 to 64 years in 2013, 
this suggests that approximately 20 million to 43 million HIV tests were conducted. HIV 
surveillance yielded 47 352 diagnoses reported in 2013,7 so STD clinics provided 
approximately 1 in 10 new case reports (n = 4766) from 1.4% to 3.1% of all tests. Overall 
HIV incidence in the United States has remained stable and was estimated at approximately 
48 000 cases in 2010,3 so new cases from STD clinics in 2013 also account for about 1 in 10 
of new diagnoses.
Early initiation of and adherence to antiretroviral therapy has substantial medical benefits to 
HIV-positive persons and prevention benefits by reducing HIV transmission to HIV-negative 
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partners by up to 96%.10,11 Therefore, in addition to increasing knowledge of HIV status 
and identification of new positives, it is critical to ensure that all HIV-positive persons 
receive necessary HIV prevention, care, and treatment services. The National HIV/AIDS 
Strategy12 has set goals of reducing new HIV infections and linking 85% of newly 
diagnosed HIV-positive persons to HIV medical care within 90 days by 2015. In 2013, only 
55.3% of newly identified HIV-positive persons in STD clinics were linked to medical care 
within 90 days, and 63.8% were linked within any time frame. Referral to partner services 
was higher at 73.5%, but interview percentages for partner services and referral to HIV 
prevention services need improvement at 62.2% and 66.9%, respectively. Linkage rates, in 
particular, could be significantly improved to ensure that HIV-positive persons have access 
to care and treatment services. Of note, African Americans were linked to HIV medical care 
with any time frame and within 90 days, referred to partner services, and interviewed for 
partner services at a much lower percentage than were Whites and Hispanics or Latinos. 
Further research is needed to understand the differences in linkage and HIV service delivery 
among certain racial/ethnic groups.
Limitations
The findings are subject to limitations. Because we focused only on CDC-funded HIV 
testing events, these findings might not be generalizable to the entire United States. Reliable 
estimates are not available to determine what proportion of all HIV tests in the United States 
is CDC-funded. Also, because of missing data, the service delivery data are likely an 
underestimate and represent the minimum percentage achieved, particularly for linkage to 
HIV medical care within 90 days. Data for target populations are only required in non–
health care settings and for HIV-positive testing events in health care settings. However, 
some jurisdictions submitted data on HIV-negative persons from health care settings and 
those data are reflected in the numbers for HIV-testing events and first-time testers.
Linkage to HIV medical care within 90 days and interview for partner services became 
CDC-required reporting variables starting in 2012. This may contribute to poorer data 
quality and incomplete data reporting on these 2 service delivery indicators because of the 
time it may take grantees to update their data systems for reporting. However, there have 
been significant improvements in data quality each year, specifically for both linkage to HIV 
medical care variables and referral data. Finally, because we used self-report to identify a 
new HIV diagnosis, the number of persons newly diagnosed as HIV-positive reported likely 
represents an overestimation of new positives.
Conclusions
Limitations notwithstanding, among CDC-funded testing events, STD clinics found a 
meaningful proportion of newly identified HIV-positive persons and are settings to target 
persons who might otherwise not seek HIV testing or medical evaluation. HIV testing in 
STD clinics has added value if the testing can be sustained through CDC funding or through 
other sources, such as reimbursement from insurance. HIV testing in health care settings is a 
US Preventive Services Task Force A recommendation and, therefore, is likely to be a 
covered service in many plans.26 The STD clinics vary considerably in the extent to which 
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they can manage third-party billing.27,28 However, the impact of changes to insurance and 
billing is an avenue for continued exploration in public clinics in general.
The success of linkage to HIV medical care varies within and across jurisdictions and 
populations,29–31 with implementation research32 the putative route to understand the 
barriers of linkage efforts so that improvements can be made. The STD clinics may 
contribute to partnerships between public health entities and HIV-care facilities. Finally, 
HIV partner services are common in STD clinic settings and a priority service for HIV.23,33 
They have value to HIV-positive persons and exposed partners by distributing prevention 
and care through social and sexual networks and serving to increase public health 
understanding of the epidemiology of HIV for prevention programs.34 Because STD clinics 
are a substantial source of newly diagnosed HIV infections and a resource for better 
understanding the HIV epidemic in the United States, they are important to HIV prevention 
and control in the United States.
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FIGURE 1. Number of HIV testing events and percentages of first-time testers and newly 
identified HIV-positive persons in US sexually transmitted disease clinics: 2011–2013
Note. First-time testers: P < .01 between all years; newly identified HIV positivity: P < .01 
between all years. The numbers of health departments with data for sexually transmitted 
disease clinics in 2011 to 2013 were 43, 54, and 56, respectively.
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FIGURE 2. Number of HIV-positive persons and percentage linked to HIV medical care in US 
sexually transmitted disease clinics: 2011–2013
Note. Linkage to HIV medical care within any time frame P < .01 between all years; linkage 
to HIV medical care within 90 days: P < .01 between 2012 and 2013. Linkage to HIV 
medical care within 90 days was a required reporting variable in 2012 and 2013.
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